Logo image of IRIX

IRIDEX CORP (IRIX) Stock Price, Quote, News and Overview

NASDAQ:IRIX - Nasdaq - US4626841013 - Common Stock - Currency: USD

1.44  -0.06 (-4.32%)

IRIX Quote, Performance and Key Statistics

IRIDEX CORP

NASDAQ:IRIX (2/24/2025, 8:00:02 PM)

1.44

-0.06 (-4.32%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High3.65
52 Week Low1.27
Market Cap23.96M
Shares16.64M
Float13.20M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)03-06 2025-03-06/amc
IPO02-16 1996-02-16


IRIX short term performance overview.The bars show the price performance of IRIX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20 -25

IRIX long term performance overview.The bars show the price performance of IRIX in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of IRIX is 1.44 USD. In the past month the price decreased by -12.2%. In the past year, price decreased by -45.45%.

IRIDEX CORP / IRIX Daily stock chart

IRIX Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 28.9 234.07B
ISRG INTUITIVE SURGICAL INC 80.63 210.79B
BSX BOSTON SCIENTIFIC CORP 41.59 153.85B
SYK STRYKER CORP 31.82 147.88B
MDT MEDTRONIC PLC 16.89 115.62B
BDX BECTON DICKINSON AND CO 16.56 66.13B
EW EDWARDS LIFESCIENCES CORP 27.77 42.91B
GEHC GE HEALTHCARE TECHNOLOGY 20.17 41.38B
IDXX IDEXX LABORATORIES INC 41.21 37.96B
DXCM DEXCOM INC 55 35.45B
RMD RESMED INC 25.98 33.73B
PHG KONINKLIJKE PHILIPS NVR- NY 17.79 24.42B

About IRIX

Company Profile

IRIX logo image IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 111 full-time employees. The company develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.

Company Info

IRIDEX CORP

1212 Terra Bella Ave

Mountain View CALIFORNIA 94043 US

CEO: David I. Bruce

Employees: 111

Company Website: https://www.iridex.com/

Investor Relations: http://phx.corporate-ir.net/phoenix.zhtml?c=112360&p=irol-irhome

Phone: 16509404700

IRIDEX CORP / IRIX FAQ

What is the stock price of IRIDEX CORP today?

The current stock price of IRIX is 1.44 USD. The price decreased by -4.32% in the last trading session.


What is the ticker symbol for IRIDEX CORP stock?

The exchange symbol of IRIDEX CORP is IRIX and it is listed on the Nasdaq exchange.


On which exchange is IRIX stock listed?

IRIX stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for IRIDEX CORP stock?

6 analysts have analysed IRIX and the average price target is 2.04 USD. This implies a price increase of 41.67% is expected in the next year compared to the current price of 1.44. Check the IRIDEX CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is IRIDEX CORP worth?

IRIDEX CORP (IRIX) has a market capitalization of 23.96M USD. This makes IRIX a Nano Cap stock.


How many employees does IRIDEX CORP have?

IRIDEX CORP (IRIX) currently has 111 employees.


What are the support and resistance levels for IRIDEX CORP (IRIX) stock?

IRIDEX CORP (IRIX) has a support level at 1.41 and a resistance level at 1.56. Check the full technical report for a detailed analysis of IRIX support and resistance levels.


Is IRIDEX CORP (IRIX) expected to grow?

The Revenue of IRIDEX CORP (IRIX) is expected to decline by -8.66% in the next year. Check the estimates tab for more information on the IRIX EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy IRIDEX CORP (IRIX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does IRIDEX CORP (IRIX) stock pay dividends?

IRIX does not pay a dividend.


When does IRIDEX CORP (IRIX) report earnings?

IRIDEX CORP (IRIX) will report earnings on 2025-03-06, after the market close.


What is the Price/Earnings (PE) ratio of IRIDEX CORP (IRIX)?

IRIDEX CORP (IRIX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.67).


What is the Short Interest ratio of IRIDEX CORP (IRIX) stock?

The outstanding short interest for IRIDEX CORP (IRIX) is 2.22% of its float. Check the ownership tab for more information on the IRIX short interest.


IRIX Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

IRIX Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to IRIX. Both the profitability and financial health of IRIX have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IRIX Financial Highlights

Over the last trailing twelve months IRIX reported a non-GAAP Earnings per Share(EPS) of -0.67. The EPS decreased by -39.58% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -36.6%
ROE -420.74%
Debt/Equity 0.55
Chartmill High Growth Momentum
EPS Q2Q%-9.09%
Sales Q2Q%-9.88%
EPS 1Y (TTM)-39.58%
Revenue 1Y (TTM)-11.33%

IRIX Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 43% to IRIX. The Buy consensus is the average rating of analysts ratings from 6 analysts.

For the next year, analysts expect an EPS growth of 10.1% and a revenue growth -8.66% for IRIX


Ownership
Inst Owners19.45%
Ins Owners3.68%
Short Float %2.22%
Short Ratio8.09
Analysts
Analysts43.33
Price Target2.04 (41.67%)
EPS Next Y10.1%
Revenue Next Year-8.66%